Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 789 across all filing types
Latest filing 2016-04-26 Annual Report
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
Annual Report 2015
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2015' for PW Medtech Group Limited and includes comprehensive sections typical of an annual report: corporate profile, milestones, financial highlights, financial summary with detailed financial statements, chairman's statement, business review, and future prospects. The content covers the full fiscal year ended December 31, 2015, with detailed financial data and management discussion. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or summary. There is no indication that this is merely an announcement of the report or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2015
2016-04-26 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is a disclosure return related to changes in issued share capital and share buybacks for a listed issuer, PW Medtech Group Limited. It details share repurchases, issued shares, prices, and compliance with listing rules. The content focuses on share repurchase activities and capital changes rather than financial results, management changes, or regulatory filings. The document is not a report or announcement of a report but a regulatory disclosure about share capital changes and buybacks. This matches the definition of a Transaction in Own Shares (POS) filing, which covers company buybacks or sales of its own shares.
2016-04-18 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is a disclosure return related to changes in issued share capital and share buybacks by PW Medtech Group Limited. It includes detailed information on share repurchases, dates, prices, and confirmations of compliance with listing rules. The content focuses on reporting share repurchase activity rather than announcing a new report or providing financial results. This matches the description of a Transaction in Own Shares (POS) filing, which reports company buybacks or sales of its own shares. The document length and detail confirm it is the report itself, not just an announcement. Therefore, the correct classification is POS.
2016-04-12 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is a disclosure return related to changes in issued share capital and share buybacks by PW Medtech Group Limited. It includes detailed information on share repurchases, issued shares, prices, and compliance with listing rules. The content focuses on reporting share capital changes and repurchase activities rather than announcing a new share issue or capital restructuring. This fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares. The document is not an announcement of a report publication, nor is it a full financial report or regulatory filing unrelated to share transactions. Therefore, the classification is POS with high confidence.
2016-04-08 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is a disclosure return related to changes in issued share capital and share buybacks by PW Medtech Group Limited. It details share repurchases, including dates, quantities, and prices, and confirms compliance with listing rules. The content focuses on share repurchase activity rather than financial results, management changes, or regulatory filings. This matches the description of a Transaction in Own Shares (POS) filing, which reports company buybacks or sales of its own shares. The document length and detail confirm it is the report itself, not just an announcement. Therefore, the appropriate classification is POS.
2016-04-07 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is a disclosure return related to changes in issued share capital and share buybacks for a listed issuer, PW Medtech Group Limited. It includes detailed information on share repurchases, dates, prices, and confirmations of compliance with listing rules. The content focuses on share capital changes and repurchase activities rather than financial results, management changes, or regulatory filings. This matches the description of a Transaction in Own Shares (POS) filing, which reports company buybacks or sales of its own shares. The document length and detail confirm it is the report itself, not just an announcement or certification.
2016-04-01 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.